secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001493152-26-004068
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions starts clinical studies for FDA 510(k) submission to detect codeine via fingerprint
--------------------------------------------------------------------------------

- Partnered with Cliantha Research for a study in 40 adults to establish codeine detection cut-off levels.
- Study uses Intelligent Fingerprinting Drug Screening System with DSR-Plus reader; full data analysis expected by end of March 2026.
- Data will support FDA 510(k) submission and planned commercial launch into the multi-billion-dollar U.S. drug screening market.
- Company notes over 500,000 tests already sold outside the U.S.; targeting workplace, clinical, and law enforcement segments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226004068/0001493152-26-004068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226004068/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer